✦ LIBER ✦

208 HGS-ETR1, a fully human monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand death receptor 1 (TRAIL-R1) in patients with advanced solid cancer: results of a phase I trial

✍ Scribed by S.J. Hotte; A.M. Oza; L.H. Le; M. MacLean; A. Iacobucci; A. Corey; N.L. Fox; H.W. Hirte

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

30 A phase I clinical trial of HGS-ETR1,

✍ R.B. Cohen; N.J. Meropol; K.M. Padavic; N.L. Fox; A. Corey; M. Fleming; M. Mita; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Phase II Trial of Mapatumumab, a Fully H

✍ von Pawel, Joachim; Harvey, Jimmie H.; Spigel, David R.; Dediu, Mircea; Reck, Ma 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 569 KB

197 A phase I and pharmacokinetic (PK) s

✍ J. de Bono; G. Attard; R. Plummer; S. Pacey; C. Bale; L. Vidal; A. Greystoke; N. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Phase II trial of mapatumumab, a fully h

✍ Trarbach, T; Moehler, M; Heinemann, V; Köhne, C-H; Przyborek, M; Schulz, C; Snel 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 318 KB

Phase 1 study of ganitumab (AMG 479), a

✍ Haruyasu Murakami, Toshihiko Doi, Nobuyuki Yamamoto… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 228 KB